Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Crinetics Pharmaceuticals Inc
CRNX
$
15.83
-0.44%
Wed March 31st, 2021
03:25
Earnings
Analysis
Crinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
Seeking Alpha
02:24
Earnings
Analysis
Crinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha
Sun February 28th, 2021
09:38
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Crinetics Pharmaceuticals (CRNX) Investor Presentation - Slideshow
Seeking Alpha
Fri January 22nd, 2021
20:33
Analysis
Crinetics Pharmaceuticals (CRNX) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow
Seeking Alpha
Mon November 9th, 2020
16:04
Earnings
Analysis
Guide
Should You Buy Crinetics Pharmaceuticals (CRNX) Ahead of Earnings?
Zacks
Tue October 6th, 2020
20:22
IPO
Analysis
Spruce Biosciences Proposes $75 Million IPO Terms
Seeking Alpha
Tue September 1st, 2020
17:35
Analysis
Crinetics Pharmaceuticals- Superior Molecules In Endocrinology
Seeking Alpha
Tue June 30th, 2020
16:31
Analysis
Chiasma's Valuation Should Be Higher Than $5-6/Share Now That Mycapssa Is FDA Approved
Seeking Alpha
Fri June 19th, 2020
14:05
Analysis
Crinetics Pharmaceuticals, Inc. (CRNX) Shares March Higher, Can It Continue?
Zacks
Wed May 27th, 2020
11:30
Press Releases
Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources
Benzinga
